Sastasundar Ventures Ltd

Sastasundar Ventures Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a 4.16% rise in the latest session, key technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the recent price action, momentum oscillators, and moving averages to provide a comprehensive view of the stock’s current technical health and outlook.

Sastasundar Ventures Ltd, a micro-cap player in the Healthcare Services sector, has recently formed a Death Cross, a technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock's medium to long-term momentum and investor sentiment.

Sastasundar Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Sastasundar Ventures Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and others, signalling a nuanced outlook for investors amid recent price fluctuations and market comparisons.

Sastasundar Ventures Ltd, a micro-cap player in the Healthcare Services sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a modest day change of -0.18%, the stock’s technical indicators present a nuanced picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments, contextualising them within the company’s price action and broader market performance.

Sastasundar Ventures Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s technical indicators present a complex picture, reflecting mixed signals that investors must carefully analyse amid broader market movements.

Sastasundar Ventures Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 20 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Sastasundar Ventures Ltd (NSE: 710320), a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, signalling a transition from sideways trading to a mildly bearish trend. Despite some mildly bullish monthly indicators, the overall technical landscape suggests caution for investors as the stock faces downward pressure amid mixed signals from key momentum and volume indicators.

Sastasundar Ventures Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. The stock’s recent downgrade to a Strong Sell rating by MarketsMOJO underscores growing concerns despite pockets of resilience in its long-term returns.

Sastasundar Ventures Ltd, a key player in the Healthcare Services sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this, the company’s overall technical indicators present a mixed picture, with some signals suggesting caution while others hint at potential upside. This nuanced technical landscape comes amid a backdrop of moderate price movement and a recent downgrade in the company’s Mojo Grade to Strong Sell, reflecting ongoing investor scepticism.

Sastasundar Ventures Ltd has been downgraded from a Sell to a Strong Sell rating as of 20 Feb 2026, reflecting deteriorating technical indicators and weak financial fundamentals. Despite a market-beating one-year return of 23.37%, the company faces significant challenges in valuation, profitability, and technical momentum, prompting a reassessment of its investment appeal.

Sastasundar Ventures Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.56%, the stock’s technical indicators reveal a sideways trend, prompting a reassessment of its near-term outlook amid a Strong Sell rating upgrade from Sell by MarketsMOJO.

Sastasundar Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Sastasundar Ventures Ltd, a key player in the Healthcare Services sector, has witnessed a marked shift in its valuation parameters, moving from a risky to a very expensive rating. Despite a modest share price decline of 0.45% on 10 Feb 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have surged, raising questions about its price attractiveness relative to historical and peer benchmarks.

Sastasundar Ventures Limited, a micro-cap healthcare services company with a market capitalisation of ₹950.00 crores, reported a consolidated net loss of ₹12.69 crores in Q2 FY26 (July-September 2025), marking a sharp reversal from the ₹23.91 crores profit posted in the previous quarter. The 153.07% quarter-on-quarter decline and 88.40% year-on-year deterioration underscore mounting operational challenges that have plagued the Kolkata-based firm throughout FY26.